Medicines & vaccines · South Korea

SK bioscience

Developed SKYCovione, Korea's first domestic COVID-19 vaccine (with GSK adjuvant and University of Washington design), and is a CEPI partner for rapid-response vaccines.

Headquarters
Seongnam, South Korea · East Asia
Value chain
Medicines & vaccines(Products); also Contract manufacturing
What that means
Develops and sells therapeutics under its own name: drugs, biologics, vaccines, cell and gene therapies and radiopharmaceuticals.
Founded
2018
Ownership
Listed
Listing
KRX:302440 on Google Finance
Website
skbioscience.com
Relevance
Low at its strongest, in Advanced Therapeutics, Vaccines & Medical Countermeasures

In 2 capabilities

Each capability the company is listed in, most relevant first: how experts in the field see its global relevance there, why it is listed and the source.

  1. Biotechnology & Health Technologies · Manufacture · listed #29 of 50

    Developed SKYCovione, Korea's first domestic COVID-19 vaccine (with GSK adjuvant and University of Washington design), and is a CEPI partner for rapid-response vaccines.

    Relevance: Korean vaccine developer

    Source · en.wikipedia.org

  2. Biotechnology & Health Technologies · Manufacture · listed #35 of 50

    Korea's leading vaccine manufacturer with the Andong L House plant, which produced Novavax and AstraZeneca COVID vaccines and its own SKYCovione.

    Relevance: Korean vaccine manufacturer

    Source · en.wikipedia.org